Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

quality of life of people all over the world. A. Menarini Diagnostics is part of the Menarini Group, a multinational pharmaceutical, biotechnology and diagnostics company headquartered in Florence, Italy, with more than 17,000 employees in 140...

IKA introduces new accessories for the HABITAT research bioreactor.

dedicated to advancing scientific research and industrial applications. Serving industries such as life sciences, pharmaceuticals, and chemicals, we help drive progress and improve lives. With over 900 employees at 16 locations on four continents,...

Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer

where she managed investment in novel therapeutic modality platforms, having previously served as Director of Takeda Pharmaceuticals' Gastroenterology Drug Discovery Unit where she helped build the microbiome therapeutics portfolio spanning...

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

the company’s Life Science business achieved EXCiPACT cGMP (current Good Manufacturing Practice) certification for Pharmaceutical Auxiliary Materials (PAMs) at its major global Cell Culture Media (CCM) production sites. EXCiPACT is a widely...

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

future opportunities.” About Cygnus Technologies, LLC: Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics as well as...

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, announced that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug ("IND")...

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

and in major markets across specialty and primary care. Ms. Phelan also currently sits on the boards of Medexus Pharmaceuticals and FemmePharma Consumer Healthcare. “I’m delighted to have such a passionate, data-driven expert leading one of our...

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

ImmPACT Bio USA Inc.a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to patients, announced the United States Food and Drug Administration (FDA)...

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

disease. We are committed to a future without liver disease. About Gilead Sciences: Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating...

Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis

manufactured with strict quality controls intended to meet FDA’s guidelines for reliability. They offer biotech and pharmaceutical companies effective and reliable single or two-shot intranasal delivery for a variety of medicines including for...

Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity

Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy aging, is excited to announce the development of a novel, science-backed skincare treatment aimed at targeting some of the root causes...

Spencer Trask & Co. launches Signal12 for Dry Eye Disease treatment, led by former Aerie executives, advancing Pro-ocular through trials

Signal12 as president and chief executive officer. Mitro is the former president and chief operating officer of Aerie Pharmaceuticals, where he grew annual sales to more than $100 million and facilitated a $770 million acquisition by Swiss eye-care...

Persist AI and Nivagen partner to develop AI-driven manufacturing for long-acting injectables

over weeks or months, improving patient adherence and outcomes. "We are excited to partner with Nivagen, a leading Pharmaceutical company with extensive experience and expertise in manufacturing and distributing pharmaceutical products. Together,...

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

Citius Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LYMPHIR™ (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of r/r cutaneous T-cell lymphoma (CTCL) after at least one prior...

Axion BioSystems extends its agreement with Corning®, granting exclusive rights to distribute its award-winning cell counting device.

also includes impedance-based analyzers, automated imaging systems, and high-quality consumables used in academic, pharmaceutical, and biotech labs around the world. About Axion BioSystems: Axion BioSystems is a leading life sciences tools company...

Formosa licenses Clobetasol Propionate Ophthalmic Suspension to Apotex for ocular surgery relief

Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Canada to the commercialization of clobetasol propionate ophthalmic suspension,...

Sensitech acquires Berlinger & Co. to expand life sciences cold chain solutions

company that specializes in innovative and customized solutions for monitoring temperature-sensitive goods in the pharmaceutical and life science, clinical trial and global health segments. Sensitech is part of Carrier Global Corporation global...

Jade Biosciences launches with $80 million to develop transformative autoimmune disease therapies

D.V.M., Ph.D., as Chief Scientific Officer, bringing more than 15 years of leadership experience across biotech and pharmaceutical industries to the organization. Dr. King previously served as Chief Scientific Officer of Chinook Therapeutics, a...

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

research in specialized therapeutic areas, reinforcing their commitment to the community and the broader medical and pharmaceutical industry. "We are excited to welcome Tidewater Clinical Research to the Eximia network," says Grach. "Their...

Inoviv launches MasterKey™, a customizable platform for multiplexed protein assays

with Inoviv has been a productive collaboration," said Kristofer Fritz, PhD, Associate Professor in the Department of Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. "Their expertise in identifying correlative...